RIPK3–MLKL necroptotic signalling amplifies STING pathway and exacerbates lethal sepsis
Clinical and Translational Medicine · 2023-07 · 13 (7)
DOI: 10.1002/ctm2.1334 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, online erschienen am 20.07.2023. Verfasst von Xufei Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of General Surgery, Jinling Hospital, School of Medicine, Southeast University, Nanjing, China. Hauptthemen laut MEDLINE: Protein Kinases, Sepsis. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.
Themen: Sepsis
Abstract (Originalsprache)
Backgrounds The stimulator of interferon genes (STING) is an important driver in various inflammatory diseases. Methods and results Here, we have demonstrated that inhibition of RIPK3 and MLKL dampens STING signaling, indicating that necroptosis may be involved in sustaining STING signaling. Furthermore, RIPK3 knockout in HT‐29 cells significantly suppressed STING signaling. Mechanistically, RIPK3 inhibits autophagic flux during STING activation. RIPK3 knockout inhibits STING signaling by intensifying STING autophagy. In contrast, MLKL regulates the STING pathway bidirectionally. MLKL deficiency enhances STING signaling, whereas suppression of MLKL‐mediated pore formation restricts STING signaling. Mechanistically, upon abrogating the pro‐necroptotic activity of MLKL, MLKL bound to activated STING is secreted to the extracellular space, where it restricts TBK1 and IRF3 recruitment. Targeting necroptotic signaling ameliorates STING activation during DMXAA‐induced intestinal injury and sepsis. Conclusions These findings elucidate molecular mechanisms linking necroptosis to the STING pathway, and suggest a potential benefit of therapeutic targeting of necroptosis in STING‐driven inflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Institute of General Surgery, Jinling Hospital, School of Medicine, Southeast University, Nanjing, China.
- Research Center of Surgery, BenQ Medical Center, the Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, China.
- Research Institute of General Surgery, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
ORCID-Profile: Jianan Ren
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
Zitieren
APA
Zhang, X., Wu, J., Liu, Q., Li, X., Yang, Y., Wu, L., Wu, X., Zhao, Y., & Ren, J. (2023). RIPK3–MLKL necroptotic signalling amplifies STING pathway and exacerbates lethal sepsis. Clinical and Translational Medicine, 13(7). https://doi.org/10.1002/ctm2.1334
Vancouver
Zhang X, Wu J, Liu Q, Li X, Yang Y, Wu L, et al. RIPK3–MLKL necroptotic signalling amplifies STING pathway and exacerbates lethal sepsis. Clinical and Translational Medicine. 2023;13(7). doi:10.1002/ctm2.1334
BibTeX
@article{Zhang2023,
author = {Zhang, Xufei and Wu, Jie and Liu, Qinjie and Li, Xuanheng and Yang, Yiyu and Wu, Lei and Wu, Xiuwen and Zhao, Yun and Ren, Jianan},
title = {RIPK3–MLKL necroptotic signalling amplifies STING pathway and exacerbates lethal sepsis},
journal = {Clinical and Translational Medicine},
year = {2023},
volume = {13},
number = {7},
doi = {10.1002/ctm2.1334}
}
EUVIMED